Neuropeptides: general characteristics and neuropharmaceutical potential in treating CNS disorders.
The general characteristics of neuropeptides are discussed as a background for the understanding of their role in regulation of physiological systems. The extent of those systems that are crucially affected by neuropeptides is vast and the complexity of their interactions makes the clinical focus on a specific neuropeptide unsatisfactory. The clinical potential of neuropeptides affecting eating disorders, CNS behavioral disorders and the neuroregenerative and neuroprotective action of neuropeptides is discussed. It is probable that successful neuropeptide therapeutics will depend upon the application of translational and combinational research using various ingenious combinations of neuropeptides, their agonists and antagonists, neuropeptide receptor agonists and antagonists, improved methods of delivery and the development of peptides targeted to the genetic profile of individual patients.
Strand
Fleur L
FL
New York University, 340 East 64th Street, New York, NY 10021, USA. fleur.strand@nyu.edu
D000818:Animals; D002493:Central Nervous System Diseases / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D009479:Neuropeptides / Q000378:metabolism / Q000627:therapeutic use*; D018013:Receptors, Neuropeptide / Q000378:metabolism; D013678:Technology, Pharmaceutical / Q000379:methods / Q000639:trends*
D009479:Neuropeptides; D018013:Receptors, Neuropeptide